A Multicenter, Randomized, Open-label, Parallel-group Study of Paclitaxel Liposome and Cisplatin Compared With Gemcitabine and Cisplatin as First-line Therapy in Advanced Squamous Non-Small-Cell Lung Cancer
Latest Information Update: 02 Feb 2022
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary) ; Gemcitabine
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms LIPUSU
- Sponsors Luye Pharma Group
- 31 Jan 2021 Results presented at the 2020 World Conference on Lung Cancer
- 14 Dec 2020 According to a Luye Pharma Group Media Release, the study led by Shanghai Pulmonary Hospital.
- 14 Dec 2020 Status changed from active, no longer recruiting to completed, according to a Luye Pharma Group Media Release.